Buyout PE
Arsenal Capital Partners
Arsenal Capital Partners acquires controlling stakes in established, profitable businesses, from United States. It states a focus on healthcare & life sciences and industrials & manufacturing.
SEC filings
What Arsenal Capital Partners has raised
From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.
| Vehicles filed | 10 |
| Total capital raised | $1.8bn |
| Largest single vehicle | $906m |
| Filing history | 2015 to 2021 |
| Smallest accepted commitment | $1 |
| Filed from | NEW YORK |
Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.
Regulatory record
How Arsenal Capital Partners is registered
From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.
| Adviser status | SEC registered |
| Regulatory assets under management | $9.7bn |
| Employees | 91 |
| Private funds advised | 27 · $9.7bn gross |
| SEC adviser number | CRD 156896 |
Portfolio
Disclosed holdings
Companies Arsenal Capital Partners lists on its own website. No investment years are published. 2 have a recorded transaction against them in the deal archive.
| Company | Invested | Years held | Recorded transaction |
|---|---|---|---|
| 3DR Labs | — | — | — |
| ATP Adhesive | — | — | — |
| Accella | — | — | — |
| Airnov | — | — | $320m 2019 |
| AvCarb | — | — | — |
| BioIVT | — | — | — |
| CPS Performance | — | — | — |
| CellCarta | — | — | — |
| Certara | — | — | $850m 2017 |
| Charter Brokerage | — | — | — |
| Chromaflo | — | — | — |
| Headwall | — | — | — |
Compiled from Arsenal Capital Partners’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.
Recorded transactions
Buying and selling
Deals in which Arsenal Capital Partners is named as buyer or seller in the transaction archive. 3 recorded exits, most recently in 2017. 3 recorded acquisitions.
| Company | Side | Counterparty | Year | Consideration |
|---|---|---|---|---|
| Seal For Life Industries | Bought | Berry | 2019 | $328m |
| Airnov | Bought | Clariant AG | 2019 | $320m |
| Accella Performance Materials | Sold | Carlisle Companies | 2017 | $670m |
| Spartech | Bought | Avient | 2017 | $115m |
| Certara | Sold | EQT | 2017 | $850m |
| Flowchem | Sold | KMG Chemicals | 2017 | $495m |
Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.
Valuation context
Transaction values in Healthcare & Life Sciences
What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.
The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Is this Arsenal Capital Partners?
Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.
Claim or correct this profileTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.
Comparable investors
Similar mandates
Other buyout pe investors active in healthcare & life sciences.